Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2015

01.03.2015 | General Gynecology

Functional outcome after pelvic floor reconstructive surgery with or without concomitant hysterectomy

verfasst von: Juliane Farthmann, Dirk Watermann, Thalia Erbes, Katrin Roth, Petia Nanovska, Gerald Gitsch, Boris Gabriel

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

When counseling patients about surgical alternatives for pelvic organ prolapse (POP) repair, numerous things have to be considered. Uterine preservation vs. hysterectomy is one relevant issue. Hysterectomy has been traditionally performed for POP, but its benefit regarding outcome has never been proven. Furthermore, a growing number of women ask for uterine preservation.

Methods

In this retrospective cohort study, 384 patients who had undergone surgery for POP between 2000 and 2012 at Freiburg University Medical Center were included. Using a standardized questionnaire, further surgeries, urinary incontinence, recurrent POP, pessary use, and satisfaction with the surgical outcome were evaluated. The functional results after uterine preservation vs. concomitant hysterectomy were compared using t test.

Results

196 (51.04 %) women were available for follow-up and agreed to participate (n = 122 with hysterectomy, n = 72 with uterine-preserving surgery, respectively). After a mean follow-up time of 67 months, vaginal bulge symptoms and urinary incontinence did not differ between treatment groups. We observed higher success rates and satisfaction scores in the uterine-preserving group. Regarding satisfaction with surgery and whether the patients thought it had been successful, we observed a trend toward better results in the uterine-preserving group (mean satisfaction score: 8.45 ± 2.15 vs. 7.76 ± 2.91, range 0–10, p = 0.061; success: 91.4 vs. 81.7 %, p = 0.087).

Conclusions

There was no difference with regard to functional outcome between patients with or without concomitant hysterectomy. Satisfaction with the operation was slightly higher after uterus preserving surgery. Therefore, uterine-preserving surgery is a valuable option unless there are contraindications.
Literatur
1.
Zurück zum Zitat Smith FJ, Holman CD, Moorin RE, Tsokos N (2010) Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol 116(5):1096–1100PubMedCrossRef Smith FJ, Holman CD, Moorin RE, Tsokos N (2010) Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol 116(5):1096–1100PubMedCrossRef
2.
Zurück zum Zitat Maher C, Feiner B, Baessler K, Schmid C (2013) Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev; 4:CD004014. Review Maher C, Feiner B, Baessler K, Schmid C (2013) Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev; 4:CD004014. Review
3.
Zurück zum Zitat Cheon C, Maher C (2013) Economics of pelvic organ prolapse surgery. Int Urogynecol J 24(11):1873–1876PubMedCrossRef Cheon C, Maher C (2013) Economics of pelvic organ prolapse surgery. Int Urogynecol J 24(11):1873–1876PubMedCrossRef
4.
Zurück zum Zitat Lykke R, Blaakær J, Ottesen B, Gimbel H (2013) Hysterectomy in Denmark 1977–2011: changes in rate, indications, and hospitalization. Eur J Obstet Gynecol Reprod Biol; pii: S0301-2115(13)00461-2 Lykke R, Blaakær J, Ottesen B, Gimbel H (2013) Hysterectomy in Denmark 1977–2011: changes in rate, indications, and hospitalization. Eur J Obstet Gynecol Reprod Biol; pii: S0301-2115(13)00461-2
5.
Zurück zum Zitat Walters MD, Ridgeway BM (2013) Surgical treatment of vaginal apex prolapse. Obstet Gynecol 121(2 Pt 1):354–374PubMed Walters MD, Ridgeway BM (2013) Surgical treatment of vaginal apex prolapse. Obstet Gynecol 121(2 Pt 1):354–374PubMed
6.
Zurück zum Zitat Rosati M, Bramante S, Bracale U, Pignata G, Azioni G (2013) Efficacy of laparoscopic sacrocervicopexy for apical support of pelvic organ prolapse. JSLS. 17(2):235–244PubMedCentralPubMedCrossRef Rosati M, Bramante S, Bracale U, Pignata G, Azioni G (2013) Efficacy of laparoscopic sacrocervicopexy for apical support of pelvic organ prolapse. JSLS. 17(2):235–244PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Lee T, Rosenblum N, Nitti V, Brucker BM (2013) Uterine sparing robotic-assisted laparoscopic sacrohysteropexy for pelvic organ prolapse: safety and feasibility. J Endourol 27(9):1131–1136PubMedCrossRef Lee T, Rosenblum N, Nitti V, Brucker BM (2013) Uterine sparing robotic-assisted laparoscopic sacrohysteropexy for pelvic organ prolapse: safety and feasibility. J Endourol 27(9):1131–1136PubMedCrossRef
8.
Zurück zum Zitat Bonney V (1934) The principles that should underline all operations for prolapse. J Obstet Gynaecol Br Empire 41:669–683CrossRef Bonney V (1934) The principles that should underline all operations for prolapse. J Obstet Gynaecol Br Empire 41:669–683CrossRef
9.
Zurück zum Zitat Jeppson PC, Sung VW (2013) Hysterectomy for pelvic organ prolapse: indications and techniques. Clin Obstet Gynecol Jeppson PC, Sung VW (2013) Hysterectomy for pelvic organ prolapse: indications and techniques. Clin Obstet Gynecol
10.
11.
Zurück zum Zitat Persson P, Brynhildsen J, Kjølhede P (2013) Hysterectomy Multicentre Study Group in South-East Sweden. Pelvic organ prolapse after subtotal and total hysterectomy: a long-term follow-up of an open randomised controlled multicentre study. BJOG 120(12):1556–1565PubMed Persson P, Brynhildsen J, Kjølhede P (2013) Hysterectomy Multicentre Study Group in South-East Sweden. Pelvic organ prolapse after subtotal and total hysterectomy: a long-term follow-up of an open randomised controlled multicentre study. BJOG 120(12):1556–1565PubMed
12.
Zurück zum Zitat Collinet P, Belot F, Debodinance P, Ha Duc E, Lucot JP, Cosson M (2006) Transvaginal mesh technique for pelvic organ prolapse repair: mesh exposure management and risk factors. Int Urogynecol J Pelvic Floor Dysfunct 17(4):315–320PubMedCrossRef Collinet P, Belot F, Debodinance P, Ha Duc E, Lucot JP, Cosson M (2006) Transvaginal mesh technique for pelvic organ prolapse repair: mesh exposure management and risk factors. Int Urogynecol J Pelvic Floor Dysfunct 17(4):315–320PubMedCrossRef
13.
Zurück zum Zitat Caquant F, Collinet P, Debodinance P, Berrocal J, Garbin O, Rosenthal C, Clave H, Villet R, Jacquetin B, Cosson M (2008) Safety of transvaginal mesh procedure: retrospective study of 684 patients. J Obstet Gynaecol Res 34(4):449–456PubMedCrossRef Caquant F, Collinet P, Debodinance P, Berrocal J, Garbin O, Rosenthal C, Clave H, Villet R, Jacquetin B, Cosson M (2008) Safety of transvaginal mesh procedure: retrospective study of 684 patients. J Obstet Gynaecol Res 34(4):449–456PubMedCrossRef
14.
Zurück zum Zitat Farthmann J, Watermann D, Niesel A, Fünfgeld C, Kraus A, Lenz F, Augenstein HJ, Graf E, Gabriel B (2013) Lower exposure rates of partially absorbable mesh compared to nonabsorbable mesh for cystocele treatment: 3-year follow-up of a prospective randomized trial. Int Urogynecol J 24(5):749–758PubMedCrossRef Farthmann J, Watermann D, Niesel A, Fünfgeld C, Kraus A, Lenz F, Augenstein HJ, Graf E, Gabriel B (2013) Lower exposure rates of partially absorbable mesh compared to nonabsorbable mesh for cystocele treatment: 3-year follow-up of a prospective randomized trial. Int Urogynecol J 24(5):749–758PubMedCrossRef
15.
Zurück zum Zitat Costantini E, Porena M, Lazzeri M, Mearini L, Bini V, Zucchi A (2013) Changes in female sexual function after pelvic organ prolapse repair: role of hysterectomy. Int Urogynecol J 24(9):1481–1487PubMedCrossRef Costantini E, Porena M, Lazzeri M, Mearini L, Bini V, Zucchi A (2013) Changes in female sexual function after pelvic organ prolapse repair: role of hysterectomy. Int Urogynecol J 24(9):1481–1487PubMedCrossRef
16.
Zurück zum Zitat Barber MD, Brubaker L, Nygaard I, Wheeler TL 2nd, Schaffer J, Chen Z, Spino C (2009) Pelvic floor disorders network. defining success after surgery for pelvic organ prolapse. Obstet Gynecol 114(3):600–609PubMedCentralPubMedCrossRef Barber MD, Brubaker L, Nygaard I, Wheeler TL 2nd, Schaffer J, Chen Z, Spino C (2009) Pelvic floor disorders network. defining success after surgery for pelvic organ prolapse. Obstet Gynecol 114(3):600–609PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Barber MD, Maher C (2013) Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J 24(11):1783–1790PubMedCrossRef Barber MD, Maher C (2013) Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J 24(11):1783–1790PubMedCrossRef
Metadaten
Titel
Functional outcome after pelvic floor reconstructive surgery with or without concomitant hysterectomy
verfasst von
Juliane Farthmann
Dirk Watermann
Thalia Erbes
Katrin Roth
Petia Nanovska
Gerald Gitsch
Boris Gabriel
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2015
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-014-3435-x

Weitere Artikel der Ausgabe 3/2015

Archives of Gynecology and Obstetrics 3/2015 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.